Literature DB >> 4952978

Separation and estimation split "products" of fibrinogen and fibrin in human serum.

J E Niléhn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4952978

Source DB:  PubMed          Journal:  Thromb Diath Haemorrh        ISSN: 0340-5338


× No keyword cloud information.
  13 in total

1.  The effect of dextran on the lysability of ex vivo thrombi.

Authors:  M Aberg; S E Bergentz; U Hedner
Journal:  Ann Surg       Date:  1975-03       Impact factor: 12.969

2.  Antifibrinolytic properties of oxyphenbutazone in vitro.

Authors:  M Pandolfi; K Dyster-Aas; B Astedt
Journal:  Experientia       Date:  1976-02-15

3.  Fibrinolytic activity in the walls of cerebral saccular aneurysms.

Authors:  O Hassler; H Fodstad
Journal:  Acta Neurochir (Wien)       Date:  1977       Impact factor: 2.216

4.  In vitro release of fibrinolytic activators from cornea.

Authors:  E Lantz; K Dyster-Aas; M Pandolfi
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-05-16

5.  Release of plasminogen activator from normal and neoplastic endometrium.

Authors:  L Svanberg; B Astedt
Journal:  Experientia       Date:  1979-06-15

6.  Release of fibrinolytic activators from human tumours cultured in vitro.

Authors:  G Björlin; M Pandolfi; B Astedt
Journal:  Experientia       Date:  1972-07-15

7.  Quantitation of fibrinolytic agents released in tissue culture.

Authors:  B Astedt; M Pandolfi; I M Nilsson
Journal:  Experientia       Date:  1971-03-15

8.  Assay of serum fibrin degradation products by agglutination-inhibition of coated erythrocytes.

Authors:  P C Das
Journal:  J Clin Pathol       Date:  1970-05       Impact factor: 3.411

9.  Origin of urinary fibrin/fibrinogen degradation products in glomerulonephritis.

Authors:  M Ekberg; M Pandolfi
Journal:  Br Med J       Date:  1975-04-05

10.  Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).

Authors:  H Fodstad; I M Nilsson
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.